Skip to main content
Year archive

ONCOSIL MEDICAL LTD — 2005 filings

All 45 regulatory filings released by ONCOSIL MEDICAL LTD (OSL) in 2005, sourced directly from the official regulator.

45 Filings
2005 Period
2005 filings (45)
Filing Released Lang
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-12-18 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-12-15 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-12-12 English
Amended Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-12-12 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-12-07 English
Enters into Revenue Contract with Major US Pharmaceutical Co 2 pages ?Kb
Regulatory Filings
2005-12-05 English
NeuroSolutions enters into revenue contracts with GSK 2 pages ?Kb
Regulatory Filings
2005-11-17 English
AGM 2005 Presentation 15 pages ?Kb
Regulatory Filings
2005-11-17 English
Results of Meeting 2 pages ?Kb
Regulatory Filings
2005-11-17 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-11-17 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-11-17 English
Appendix 3B 8 pages ?Kb
Regulatory Filings
2005-11-17 English
NeuroSolutions to Exhibit at NeuroScience 2005 Conference 2 pages ?Kb
Regulatory Filings
2005-11-09 English
NeuroSolutions enters into another revenue contract with GSK 2 pages ?Kb
Regulatory Filings
2005-10-20 English
Commitments Test Entity - First Quarter Report 5 pages ?Kb
Regulatory Filings
2005-10-20 English
Quarterly Highlights 2 pages ?Kb
Regulatory Filings
2005-10-20 English
Notice of Annual General Meeting 17 pages ?Kb
Regulatory Filings
2005-10-06 English
Neurosolutions enters into a revenue contract with Alzhyme 2 pages ?Kb
Regulatory Filings
2005-10-05 English
Appendix 3B 9 pages ?Kb
Regulatory Filings
2005-09-29 English
Neurosolutions & Senexis enter into revenue contract 2 pages ?Kb
Regulatory Filings
2005-09-26 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-09-19 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-09-06 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-09-06 English
NeuroSolutions & GlaxoSmithKline enter Revenue Contract 2 pages ?Kb
Regulatory Filings
2005-09-05 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2005-09-01 English
Annual Report 46 pages ?Kb
Regulatory Filings
2005-08-30 English
Neurosolutions & Sosei file patent for lead pain compound 2 pages ?Kb
Regulatory Filings
2005-08-29 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-08-28 English
Neurosolutions appoints Manufacturer for lead drug candidate 2 pages ?Kb
Regulatory Filings
2005-08-24 English
Change of Director's Interest Notice x 2 4 pages ?Kb
Regulatory Filings
2005-08-21 English
To attend & present with GSK at World Pain Congress 2 pages ?Kb
Regulatory Filings
2005-08-15 English
Becoming a substantial holder x7 7 pages ?Kb
Regulatory Filings
2005-08-14 English
Initial Director's Interest Notice x5 10 pages ?Kb
Regulatory Filings
2005-08-14 English
Pre-Quotation Disclosure 1 page ?Kb
Regulatory Filings
2005-08-11 English
Constitution 56 pages ?Kb
Regulatory Filings
2005-08-11 English
Appendix 1A - ASX Listing application & agreement 21 pages ?Kb
Regulatory Filings
2005-08-11 English
Top 20 shareholders 1 page ?Kb
Regulatory Filings
2005-08-11 English
Spread of Holdings 1 page ?Kb
Regulatory Filings
2005-08-11 English
Incentive Option Scheme 16 pages ?Kb
Regulatory Filings
2005-08-11 English
Confirmation of completion of share sale agreements 1
Regulatory Filings
2005-08-11 English
Corporate Governance 8 pages ?Kb
Regulatory Filings
2005-08-11 English
List of Escrowed Securities 1 page ?Kb
Regulatory Filings
2005-08-11 English
Admission to Official List 3 pages ?Kb
Regulatory Filings
2005-08-10 English
NeuroDiscovery closes IPO and Completes Acquisition 2 pages ?Kb
Regulatory Filings
2005-08-10 English
Disclosure Document 75 pages ?Kb
Regulatory Filings
2005-07-13 English